Long-term use of rituximab associated with lower rates of AAV relapse
1. In this randomized controlled trial involving patients with antineutrophil cytoplasmic antibody-associated vasculitis in complete remission, administration of rituximab for ...
Tag: Granulomatosis with polyangiitis
Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis
1. In this study of decedents from 1999 to 2017, mortality due to antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) -related illness ...
Rituximab noninferior to conventional therapy in ANCA-associated vasculitis: RAVE Trial
Image: PD/Rituximab (Rituxan, MabThera) 1. At 18 months, patients with ANCA-associated vasculitis treated with one course of rituximab had similar ...
